Joseph Monahan

Insider Reports History

Location
Wayne, PA
Signature
/s/ Matthew Rothman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joseph Monahan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aclaris Therapeutics, Inc. Chief Scientific Officer Common Stock 265,662 $528,667 $1.99 01 Mar 2025 Direct
Aclaris Therapeutics, Inc. Chief Scientific Officer Restricted Stock Units 10,925 $21,741 $1.99 01 Mar 2025 Direct
Aclaris Therapeutics, Inc. Chief Scientific Officer Common Stock 193 $384 $1.99 01 Mar 2025 By Spouse
Aclaris Therapeutics, Inc. Chief Scientific Officer Employee Stock Option (Right to Buy) 293,500 03 Feb 2025 Direct

Insider Reports Filed by Joseph Monahan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACRS Aclaris Therapeutics, Inc. 01 Mar 2025 5 -$54,243 4 Chief Scientific Officer 04 Mar 2025, 16:15
ACRS Aclaris Therapeutics, Inc. 01 Feb 2025 7 -$28,066 4 Chief Scientific Officer 04 Feb 2025, 16:15
ACRS Aclaris Therapeutics, Inc. 31 Dec 2024 7 $0 4 Chief Scientific Officer 03 Jan 2025, 18:25
ACRS Aclaris Therapeutics, Inc. 10 Dec 2024 1 $0 4 Chief Scientific Officer 12 Dec 2024, 16:15
ACRS Aclaris Therapeutics, Inc. 01 Mar 2024 9 -$26,391 4 Chief Scientific Officer 05 Mar 2024, 17:04
ACRS Aclaris Therapeutics, Inc. 01 Feb 2024 6 -$3,100 4 Chief Scientific Officer 05 Feb 2024, 19:31
ACRS Aclaris Therapeutics, Inc. 23 Oct 2023 1 -$30,460 4 Chief Scientific Officer 25 Oct 2023, 16:28
ACRS Aclaris Therapeutics, Inc. 21 Aug 2023 1 -$43,895 4 Chief Scientific Officer 22 Aug 2023, 16:31
ACRS Aclaris Therapeutics, Inc. 20 Jun 2023 1 -$61,663 4 Chief Scientific Officer 22 Jun 2023, 16:30
ACRS Aclaris Therapeutics, Inc. 01 Mar 2023 10 -$385,639 4 Chief Scientific Officer 03 Mar 2023, 19:12
ACRS Aclaris Therapeutics, Inc. 15 Feb 2023 1 -$65,310 4 Chief Scientific Officer 17 Feb 2023, 15:34
ACRS Aclaris Therapeutics, Inc. 01 Feb 2023 2 $0 4 Chief Scientific Officer 03 Feb 2023, 16:07
ACRS Aclaris Therapeutics, Inc. 15 Dec 2022 1 -$79,412 4 Chief Scientific Officer 16 Dec 2022, 15:57
ACRS Aclaris Therapeutics, Inc. 17 Oct 2022 1 -$79,908 4 Chief Scientific Officer 19 Oct 2022, 16:45
ACRS Aclaris Therapeutics, Inc. 18 Apr 2022 1 -$488,298 4 Chief Scientific Officer 20 Apr 2022, 17:06
ACRS Aclaris Therapeutics, Inc. 10 Mar 2022 1 -$426,803 4 Chief Scientific Officer 14 Mar 2022, 16:53
ACRS Aclaris Therapeutics, Inc. 01 Mar 2022 8 $0 4 Chief Scientific Officer 03 Mar 2022, 17:11
ACRS Aclaris Therapeutics, Inc. 09 Feb 2022 1 -$4,857 4 Chief Scientific Officer 11 Feb 2022, 15:22
ACRS Aclaris Therapeutics, Inc. 01 Feb 2022 2 $0 4 Chief Scientific Officer 03 Feb 2022, 15:49
ACRS Aclaris Therapeutics, Inc. 01 Sep 2021 3 -$17,926 4 Chief Scientific Officer 02 Sep 2021, 17:39
ACRS Aclaris Therapeutics, Inc. 01 Jun 2021 4 -$471,437 4 Chief Scientific Officer 02 Jun 2021, 21:45
ACRS Aclaris Therapeutics, Inc. 05 May 2021 0 $0 3 Chief Scientific Officer 17 May 2021, 18:06